GO:1990544 mitochondrial ATP transmembrane transport: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990544 (mitochondrial ATP transmembrane transport) describes the movement of ATP across mitochondrial membranes, a process essential for cellular energy distribution.
• The mitochondrial ADP/ATP carrier (SLC25A4/ANT1) is the primary transporter that exports ATP from the matrix in exchange for ADP, driven by the mitochondrial membrane potential.
• Mitochondrial ATP-binding cassette (ABC) proteins, such as ABCB7 and ABCB10, also contribute to ATP-dependent transport across mitochondrial membranes.
• Defects in mitochondrial ATP transport are linked to mitochondrial diseases, neurodegeneration, and altered metabolic states.
• Research on this process employs knockout, point-mutation, and overexpression models to dissect transporter function and regulation.
• Understanding mitochondrial ATP transmembrane transport is critical for targeting cancer metabolism and mitochondrial dysfunction.
Description
Mitochondrial ATP transmembrane transport (GO:1990544) is the biological process by which ATP is transported across a mitochondrial membrane, either into or out of the mitochondrion. This process is fundamental to cellular energy homeostasis, as mitochondria generate ATP through oxidative phosphorylation and must export it to the cytosol to fuel numerous cellular reactions. The transport is primarily mediated by the mitochondrial ADP/ATP carrier (SLC25A4/ANT1), which exchanges matrix ATP for cytosolic ADP across the inner mitochondrial membrane. Additionally, mitochondrial ATP-binding cassette (ABC) proteins participate in ATP-dependent transport of various substrates, indirectly influencing ATP fluxes. Researchers study GO:1990544 to understand how energy is distributed within cells, how mitochondrial dysfunction contributes to disease, and how to manipulate these pathways for therapeutic benefit. The process is tightly linked to the mitochondrial membrane potential, which provides the driving force for ATP export. Dysregulation of ATP transport has been implicated in metabolic disorders, neurodegeneration, and cancer. This article provides a comprehensive overview of the mechanisms, key genes, and research methodologies associated with mitochondrial ATP transmembrane transport, based on authoritative QuickGO data and verified PubMed literature.
mitochondrial ATP transmembrane transport At A Glance
| GO ID | GO:1990544 |
|---|---|
| GO term | mitochondrial ATP transmembrane transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Transport of ATP across mitochondrial membranes |
| Key transporters | SLC25A4 (ANT1), mitochondrial ABC proteins |
| Driving force | Mitochondrial membrane potential |
| Related processes | Oxidative phosphorylation, mitochondrial permeability transition |
What Is GO:1990544?
According to the Gene Ontology, mitochondrial ATP transmembrane transport (GO:1990544) is defined as the process in which ATP is transported across a mitochondrial membrane, into or out of the mitochondrion. This encompasses both the inner and outer mitochondrial membranes and includes transport mediated by specific carrier proteins such as the ADP/ATP carrier.
Why Is mitochondrial ATP transmembrane transport Important in Cell Biology?
Mitochondrial ATP transmembrane transport is essential for cellular energy distribution, as it allows ATP generated in the mitochondrial matrix to be exported to the cytosol where it powers processes such as ion pumping, biosynthesis, and muscle contraction. Defects in this process can lead to energy failure, mitochondrial dysfunction, and a range of human diseases including mitochondrial myopathies, neurodegeneration, and cancer. Understanding the molecular players and regulatory mechanisms of ATP transport is therefore critical for developing therapeutic strategies targeting mitochondrial metabolism.
• Maintains cellular energy homeostasis by exporting ATP from mitochondria to cytosol.
• Driven by the mitochondrial membrane potential, linking transport to respiratory chain activity.
• Dysregulation contributes to mitochondrial diseases and metabolic disorders.
• Plays a role in apoptosis and mitochondrial permeability transition.
• Influences cancer cell metabolism and survival.
• Targeted by pharmacological agents that modulate mitochondrial function.
• Essential for neuronal function due to high energy demand.
• Involved in lysosomal hydrolysis regulation via ATP supply.
What Happens During mitochondrial ATP transmembrane transport?
ATP Synthesis and Matrix Accumulation
In simple terms: Mitochondria make ATP inside their matrix, building up a local supply.
ATP is synthesized in the mitochondrial matrix by ATP synthase during oxidative phosphorylation, using the proton gradient generated by the respiratory chain. This results in a high matrix ATP concentration, creating a gradient that favors ATP export.
ADP/ATP Exchange by the Mitochondrial Carrier
In simple terms: A specialized protein swaps ATP out for ADP in, like a revolving door.
The mitochondrial ADP/ATP carrier (SLC25A4/ANT1) catalyzes the electrogenic exchange of matrix ATP for cytosolic ADP across the inner mitochondrial membrane. This transport is driven by the mitochondrial membrane potential, with the negative interior favoring ATP export. Structural studies reveal an asymmetric transport mechanism involving conformational changes of the carrier.
ATP-Dependent Transport by ABC Proteins
In simple terms: Other proteins use ATP directly to pump molecules across mitochondrial membranes.
Mitochondrial ATP-binding cassette (ABC) proteins, such as ABCB7 and ABCB10, utilize ATP hydrolysis to transport specific substrates across the inner membrane. While not directly transporting ATP itself, they influence mitochondrial ATP levels and overall transport dynamics.
Regulation by Membrane Potential and Permeability Transition
In simple terms: The electrical charge across the membrane controls how fast ATP leaves.
The mitochondrial membrane potential (ΔΨm) is the primary driving force for ATP export via the ADP/ATP carrier. Conditions that dissipate ΔΨm, such as mitochondrial permeability transition pore opening, inhibit ATP transport and can lead to energy failure.
Key Genes Involved in GO:1990544 mitochondrial ATP transmembrane transport
The following genes and proteins are central to mitochondrial ATP transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A4 (ANT1) | Mitochondrial ADP/ATP carrier; exports ATP in exchange for ADP | Primary transporter; mutations cause mitochondrial DNA instability and myopathy |
| SLC25A5 (ANT2) | ADP/ATP carrier isoform | Tissue-specific expression; potential role in cancer metabolism |
| SLC25A6 (ANT3) | ADP/ATP carrier isoform | Less studied; may compensate in ANT1 deficiency |
| ABCB7 | Mitochondrial ABC transporter; iron-sulfur cluster export | Mutations cause X-linked sideroblastic anemia with ataxia |
| ABCB10 | Mitochondrial ABC transporter; involved in heme biosynthesis | Knockout leads to embryonic lethality; role in erythropoiesis |
| VDAC1 | Outer mitochondrial membrane channel; transports ATP/ADP | Regulates metabolite flux; implicated in apoptosis |
| VDAC2 | Outer mitochondrial membrane channel | Isoform-specific functions in apoptosis and metabolism |
| VDAC3 | Outer mitochondrial membrane channel | Less characterized; potential role in sperm function |
| ATP5F1A | ATP synthase subunit; produces ATP in matrix | Mutations cause mitochondrial complex V deficiency |
| ATP5F1B | ATP synthase subunit | Required for ATP synthesis; target for inhibition studies |
| NDUFA1 | Complex I subunit; contributes to proton gradient | Accessory subunit essential for complex I assembly |
| NDUFB10 | Complex I subunit | Accessory subunit; mutations affect respiratory chain |
| COX4I1 | Cytochrome c oxidase subunit; respiratory chain | Regulates oxidative phosphorylation and ATP production |
| SLC25A31 | ADP/ATP carrier isoform | Testis-specific; may support sperm motility |
| PPIF (Cyclophilin D) | Regulates permeability transition pore | Modulates ΔΨm and ATP transport under stress |
| HK1 (Hexokinase 1) | Binds VDAC; couples glycolysis to mitochondria | Regulates ATP/ADP flux and apoptosis |
| BAX | Pro-apoptotic BCL-2 family member | Influences mitochondrial membrane permeabilization |
| BAK1 | Pro-apoptotic BCL-2 family member | Cooperates with BAX in apoptosis |
How Is mitochondrial ATP transmembrane transport Regulated?
Mitochondrial ATP transmembrane transport is regulated by the mitochondrial membrane potential, which is maintained by the respiratory chain and modulated by permeability transition pore opening. Additionally, the expression and activity of the ADP/ATP carrier can be influenced by metabolic state, hormonal signals, and cellular stress. For example, respiratory chain deficiency can inhibit lysosomal hydrolysis by limiting ATP export, indicating cross-talk between mitochondrial ATP transport and autophagy.
mitochondrial ATP transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A4 | Mitochondrial myopathy, DNA instability | Knockout or point-mutation in cell lines; patient-derived fibroblasts |
| ABCB7 | X-linked sideroblastic anemia with ataxia | Knockout in erythroid cells; overexpression studies |
| ABCB10 | Erythropoietic protoporphyria-like | Knockout in K562 cells; rescue with wild-type |
| VDAC1 | Cancer, apoptosis resistance | Knockout or overexpression in cancer cell lines |
| PPIF | Ischemia-reperfusion injury | Knockout mice; point mutation to inhibit pore opening |
Mitochondrial Myopathies and Neurodegeneration
Mutations in SLC25A4 (ANT1) cause mitochondrial DNA instability and myopathy, highlighting the importance of ATP transport for muscle and neuronal function. Impaired ATP export leads to energy failure in high-demand tissues, contributing to neurodegeneration.
Cancer Metabolism
Altered expression of ADP/ATP carriers and mitochondrial ABC proteins is observed in various cancers, where they support metabolic reprogramming and cell survival. Targeting ATP transport may offer therapeutic opportunities.
Mitochondrial Permeability Transition in Disease
The permeability transition pore, regulated by cyclophilin D, can dissipate the membrane potential and inhibit ATP transport, contributing to ischemia-reperfusion injury and neurodegeneration.
From mitochondrial ATP transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A4 impair ATP export? | SLC25A4 knockout cell line (e.g., HEK293) |
| How do point mutations in SLC25A4 affect carrier function? | Point-mutation knock-in via CRISPR |
| Can overexpression of ABCB10 enhance mitochondrial ATP transport? | ABCB10 overexpression in HeLa cells |
| What is the role of VDAC1 in ATP/ADP flux? | VDAC1 knockout or tagged knock-in for imaging |
| Does cyclophilin D inhibition protect against ATP transport failure? | PPIF point mutation or knockout |
| How does respiratory chain deficiency affect ATP transport? | Complex I knockout cells |
How to Study the mitochondrial ATP transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Luciferase ATP assay | Total cellular or mitochondrial ATP levels | Quantifying ATP export after knockout |
| TMRM fluorescence | Mitochondrial membrane potential | Assessing driving force for ATP transport |
| 13C metabolic flux analysis | Flux of carbon through mitochondria | Tracing ATP-related metabolites |
| Cryo-EM | Structural conformations of transporters | Understanding ADP/ATP carrier mechanism |
| Proteomics (AP-MS) | Protein-protein interactions | Identifying regulators of ATP transport |
| Seahorse XF analyzer | Oxygen consumption and extracellular acidification | Measuring mitochondrial respiration and ATP production |
| Live-cell imaging with ATeam | Real-time ATP dynamics | Monitoring ATP transport in response to stimuli |
| CRISPR screening | Genes affecting ATP transport | Identifying novel regulators |
Measuring Mitochondrial ATP Transport
Luciferase-based ATP assays and fluorescent ATP sensors (e.g., ATeam) can monitor real-time ATP levels in mitochondrial and cytosolic compartments. Isotope tracing with 13C or 32P can quantify ATP flux across membranes.
Assessing Membrane Potential
The mitochondrial membrane potential, the driving force for ATP export, is measured using fluorescent dyes such as TMRM or JC-1. Changes in ΔΨm directly affect ATP transport rates.
Proteomic and Structural Analysis
Mass spectrometry-based proteomics can identify interacting partners of the ADP/ATP carrier, while cryo-EM and X-ray crystallography reveal conformational states during transport.
Genetic Manipulation and Rescue
CRISPR knockout, point mutation, and overexpression models are used to dissect the specific roles of transporters and accessory proteins in ATP transport.
How CRISPR Can Be Used to Study GO:1990544 mitochondrial ATP transmembrane transport
Knockout
CRISPR knockout of SLC25A4 or other transporters ablates ATP transport, leading to reduced cytosolic ATP and impaired cell function. Knockout models are used to study the consequences of transport loss and to identify compensatory pathways.
Point Mutation
Introducing point mutations in SLC25A4 that mimic human disease variants allows researchers to study the structural and functional impact on ATP transport. Such models help dissect the molecular mechanism of the carrier.
Knock-in
Knock-in of tagged versions of transporters (e.g., GFP-SLC25A4) enables live-cell imaging and proteomic analysis of ATP transport dynamics. Knock-in of disease-associated mutations provides accurate disease models.
Overexpression
Overexpression of ADP/ATP carriers or ABC proteins can enhance ATP transport capacity, useful for studying gain-of-function effects and for biotechnological applications. Overexpression models also help identify rate-limiting steps.
How EDITGENE Supports mitochondrial ATP transmembrane transport Research
Researchers studying mitochondrial ATP transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in ATP export, how mutations affect carrier function, and whether modulating its expression alters cellular energetics. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial ATP transmembrane transport research.
Frequently Asked Questions About mitochondrial ATP transmembrane transport
What is mitochondrial ATP transmembrane transport?
It is the process of moving ATP across mitochondrial membranes, into or out of the mitochondrion, as defined by GO:1990544.
What genes are involved in mitochondrial ATP transmembrane transport?
Key genes include SLC25A4 (ANT1), SLC25A5, SLC25A6, ABCB7, ABCB10, and VDAC1-3.
How is ATP transported out of mitochondria?
ATP is exported by the ADP/ATP carrier (SLC25A4) in exchange for ADP, driven by the mitochondrial membrane potential.
What is the role of the mitochondrial membrane potential in ATP transport?
The membrane potential provides the energy for electrogenic ATP/ADP exchange, with a negative interior favoring ATP export.
Which diseases are linked to defects in mitochondrial ATP transport?
Mitochondrial myopathies, neurodegeneration, sideroblastic anemia, and cancer have been associated with impaired ATP transport.
How can I study mitochondrial ATP transmembrane transport?
Use luciferase assays, fluorescent ATP sensors, membrane potential dyes, and CRISPR knockout/knock-in models.
What are mitochondrial ABC proteins?
They are ATP-binding cassette transporters in mitochondria, such as ABCB7 and ABCB10, that use ATP hydrolysis to transport substrates and influence ATP dynamics.
Can CRISPR be used to study ATP transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in ATP transport.
What is the ADP/ATP carrier?
It is a mitochondrial inner membrane protein (SLC25A4/ANT1) that exchanges ATP for ADP, essential for energy distribution.
How does respiratory chain deficiency affect ATP transport?
It can reduce the membrane potential and ATP synthesis, leading to decreased ATP export and impaired cellular functions such as lysosomal hydrolysis.
Conclusion
Mitochondrial ATP transmembrane transport (GO:1990544) is a cornerstone of cellular energy metabolism, enabling the distribution of ATP from mitochondria to the cytosol. The process is primarily mediated by the ADP/ATP carrier and modulated by membrane potential and accessory proteins. Dysregulation of this transport contributes to a spectrum of human diseases, making it a vital area of research. Leveraging CRISPR-based models and advanced methodologies, scientists can unravel the precise mechanisms and identify therapeutic targets. EDITGENE offers a comprehensive suite of services to support these investigations, from knockout to overexpression and screening.
References
- 1. Zorova LD et al.. 2018. Mitochondrial membrane potential.. Anal Biochem 552:50-59 PMID: 28711444
- 2. Bonora M et al.. 2022. Molecular mechanisms and consequences of mitochondrial permeability transition.. Nat Rev Mol Cell Biol 23(4):266-285 PMID: 34880425
- 3. Fernandez-Mosquera L et al.. 2019. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.. Autophagy 15(9):1572-1591 PMID: 30917721
- 4. Kunji ER et al.. 2016. The transport mechanism of the mitochondrial ADP/ATP carrier.. Biochim Biophys Acta 1863(10):2379-93 PMID: 27001633
- 5. Li Y et al.. 2025. Structural dynamics of the mitochondrial ADP/ATP carrier support an asymmetric transport mechanism.. Int J Biol Macromol 332(Pt 1):148348 PMID: 41120075
- 6. Burke MA et al.. 2007. Mitochondrial ATP-binding cassette proteins.. Transl Res 150(2):73-80 PMID: 17656326
- 7. Klingenberg M. 2008. The ADP and ATP transport in mitochondria and its carrier.. Biochim Biophys Acta 1778(10):1978-2021 PMID: 18510943
- 8. Stroud DA et al.. 2016. Accessory subunits are integral for assembly and function of human mitochondrial complex I.. Nature 538(7623):123-126 PMID: 27626371
